Cargando…
Gyejibongnyeong-Hwan (Gui Zhi Fu Ling Wan) Ameliorates Human Uterine Myomas via Apoptosis
Uterine leiomyomas are the most common benign neoplasms in women of reproductive age. However, non-surgical treatments for uterine myomas have not been fully evaluated. In Korea and China, Gyejibongnyeong-hwan (GBH) is widely used to treat gynecological diseases. Thus, we investigated the effects of...
Autores principales: | Lee, So Min, Choi, Eun Som, Ha, Eunyoung, Ji, Kon Young, Shin, So Jin, Jung, Jeeyoun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774280/ https://www.ncbi.nlm.nih.gov/pubmed/31607930 http://dx.doi.org/10.3389/fphar.2019.01105 |
Ejemplares similares
-
The clinical effects of Gyejibongnyeong-Hwan (Gui Zhi Fu Ling Wan) on patients with hyperlipidemia: A study protocol for a multicenter, double-blind, two-armed parallel, investigator-initiated, exploratory randomized controlled trial
por: Ko, Mi Mi, et al.
Publicado: (2023) -
Exploring the mechanisms of Gui Zhi Fu Ling Wan on varicocele via network pharmacology and molecular docking
por: Wang, Ruipeng, et al.
Publicado: (2022) -
Deciphering the Potential Pharmaceutical Mechanism of GUI-ZHI-FU-LING-WAN on Systemic Sclerosis based on Systems Biology Approaches
por: Wang, Qiao, et al.
Publicado: (2019) -
Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo Formula, Decreases Disease Activity and Soluble Vascular Adhesion Molecule-1 in Patients with Rheumatoid Arthritis
por: Nozaki, Kazuya, et al.
Publicado: (2006) -
Effectiveness of Gyejibongnyeong-Hwan for shoulder pain: study protocol for a randomised, wait-list controlled pilot trial
por: Jang, Soobin, et al.
Publicado: (2020)